Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

39.18
+0.05000.13%
Post-market: 39.180.00000.00%16:50 EDT
Volume:3.46M
Turnover:135.03M
Market Cap:45.64B
PE:65.30
High:39.39
Open:38.93
Low:38.65
Close:39.13
52wk High:40.79
52wk Low:18.83
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.66
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.89
PE(LYR):32.38

Loading ...

Teva call volume above normal and directionally bullish

TIPRANKS
·
1 hour ago

Scotiabank Keeps Their Buy Rating on Teva (TEVA)

TIPRANKS
·
Oct 02

Teva: Additional Analyses Found That Common Concurrent Psychiatric Conditions Did not Negatively Impact Ecopipam's Efficacy or Safety

THOMSON REUTERS
·
Oct 02

Update: Teva, Samsung Bioepis Partner to Develop, Commercialize Biosimilar Candidates

MT Newswires Live
·
Oct 02

TD Cowen Initiates Teva Pharmaceutical Industries at Buy With $55 Price Target

MT Newswires Live
·
Oct 01

Teva initiated with a Buy at TD Cowen

TIPRANKS
·
Oct 01

Teva, Samsung Bioepis Partner to Develop and Commercialize Biosimilar Candidates

MT Newswires Live
·
Oct 01

Press Release: TAPI (Technology & API Services) Names Serge Rogasik CEO to Lead Next Chapter of Growth and Competitiveness

Dow Jones
·
Oct 01

NYSE Order Imbalance 18799.0 Shares on Buy Side

THOMSON REUTERS
·
Sep 30

Teva Reports FDA Approval for Degevma

MT Newswires Live
·
Sep 29

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

TIPRANKS
·
Sep 29

Teva Pharmaceutical's Duvakitug Could be Validated by Merck's Tulisokibart Results, Oppenheimer Says

MT Newswires Live
·
Sep 28

J.P. Morgan Sticks to Their Buy Rating for Teva (TEVA)

TIPRANKS
·
Sep 25

NYSE Order Imbalance 23191.0 Shares on Buy Side

THOMSON REUTERS
·
Sep 25

Teva Releases Q3 2026 Aide Memoire

THOMSON REUTERS
·
Sep 24

Teva Enters Acceleration Phase of Transformation Supported by Multi-Year Launch Cycle, Oppenheimer Says

MT Newswires Live
·
Sep 24

Teva Pharmaceuticals Price Target Announced at $50.00/Share by Oppenheimer

Dow Jones
·
Sep 23

Top Teva Insider Makes Massive Multi-Million Dollar Stock Move

TIPRANKS
·
Sep 23

NYSE Order Imbalance 52798.0 Shares on Buy Side

THOMSON REUTERS
·
Sep 22

Teva presents new new real-world data on uzedy at Psych Congress

TIPRANKS
·
Sep 19